Disturbance in the Brain and Epilepsy

Published on

Epilepsy affects more than 60 million people worldwide. Bright Minds Biosciences, has a unique pipeline of 5-HT2C agonists being evaluated for the treatment of epilepsy, and testing is underway in collaboration with the National Institutes of Health to determine the best compound for the treatment of epilepsy.

Published on Biotechnology Company, Bright Minds, Bright Minds Bioscience, Bright Minds Biosciences, epilepsy, treatment of epilepsy

To be informed of the latest articles, subscribe:
You might also like:
Depression Shouldn't Hold You Back Any Longer
Depression Shouldn't Hold You Back Any Longer
Bright Minds Biosciences' Serotonin Drug Targets Neuropsychiatric Disorders
Bright Minds Biosciences' Serotonin Drug Targets Neuropsychiatric Disorders
The Psilocybin Mushroom and a Biotechnology Company
The Psilocybin Mushroom and a Biotechnology Company
Suffering From Depressing? Tips To Help You Get Through
Suffering From Depressing? Tips To Help You Get Through
Build A Healthier Lifestyle with Bright Minds Biosciences
Bright Minds Biosciences- Shaping Future with Biotechnology
Comment on this post